You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treg Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)

Recruiting
  • Psoriasis
  • Atopic Dermatitis
  • UVB treatment
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)

Recruiting
  • Systemic Inflammatory Response Syndrome
  • Allogeneic thyTreg 5.000.000
  • Allogeneic thyTreg 10.000.000
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañon
Sep 22, 2023

Heart Transplantation Trial in Madrid (Autologous thyTreg)

Recruiting
  • Heart Transplantation
  • Autologous thyTreg
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañon
Dec 5, 2022

GVHD Trial in Tampa (Cultured Treg cells)

Completed
  • Graft Versus Host Disease
  • Cultured Treg cells
  • Tampa, Florida
    H Lee Moffitt Cancer Center
Nov 2, 2022

Kidney Transplantation, Liver Transplantation Trial in Paris (Lymphapheresis)

Not yet recruiting
  • Kidney Transplantation
  • Liver Transplantation
  • Lymphapheresis
  • Paris, France
  • +1 more
Sep 9, 2021

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Idiopathic Inflammatory Myopathy, Interstitial Lung Disease Trial in Xi'an (Mycophenolate Mofetil)

Recruiting
  • Idiopathic Inflammatory Myopathy
  • Interstitial Lung Disease
  • Mycophenolate Mofetil
  • Xi'an, China
    Department of Rheumatology,the First Affiliated Hospital of Xi'a
Nov 10, 2021

Liver Transplant Trial in San Francisco (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

ALS (Amyotrophic Lateral Sclerosis) Trial in Boston, Houston (Monthly autologous Treg cells infusions + 3 times per week

Active, not recruiting
  • ALS (Amyotrophic Lateral Sclerosis)
  • Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
  • Monthly placebo infusions + 3 times per week placebo injections
  • Boston, Massachusetts
  • +1 more
Sep 29, 2021

Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • +2 more
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Apr 27, 2021

Amyotrophic Lateral Sclerosis Trial in Boston, Hackensack (RAPA-501 Autologous T cells)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • RAPA-501 Autologous T cells
  • Boston, Massachusetts
  • +1 more
Mar 1, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

Severe COVID-19 Disease Trial in Hackensack (RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo)

Terminated
  • Severe COVID-19 Disease
  • RAPA-501-Allo off-the-shelf Therapy of COVID-19
  • Placebo
  • Hackensack, New Jersey
    Hackensack University Medical Center
Nov 3, 2021

Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,

Recruiting
  • Kidney Transplant
  • +3 more
  • Polyclonal Regulatory T Cells
  • +10 more
  • Birmingham, Alabama
  • +5 more
Feb 22, 2022

GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)

Completed
  • Graft Versus Host Disease
  • Allogeneic Hematopoietic Cell Transplant Recipient
  • Regulatory T Cells
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 20, 2021

Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021

Prospective Study of White Blood Cells

Recruiting
  • Autoimmune Diseases
  • +2 more
  • White blood cell and blood collection
  • London, United Kingdom
    Quell Investigator Site 01
Apr 6, 2021

Diabetes, Type 1 Trial in Changsha (Umbilical Cord Blood Regulatory T cells Therapy, Insulin)

Recruiting
  • Diabetes Mellitus, Type 1
  • Umbilical Cord Blood Regulatory T cells Therapy
  • Insulin
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Type1 Diabetes, Autoimmune Diabetes Trial in Changsha (Liraglutide, UCB-Treg, Insulin)

Recruiting
  • Type1 Diabetes Mellitus
  • Autoimmune Diabetes
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

High Risk Hematologic Malignancies Trial in Salt Lake City (stem cell transplant, Stem cell transplant)

Terminated
  • High Risk Hematologic Malignancies
  • stem cell transplant
  • Stem cell transplant
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 10, 2020

Microparticle Delivered STING Agonist in Control of Experimental

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Blood Draw
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 20, 2023

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    28 Day Mortality Trial (no intervention)

    Recruiting
    • 28 Day Mortality
    • no intervention
    • Nanjing, Jiangsu, China
      Zhongda Hospital, Southeast University
    Nov 25, 2022